Shuttle Pharmaceuticals Holdings (SHPH) Intangibles (2025 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Intangibles of $9.2 million for Q1 2026, down 8.62% quarter-over-quarter from $10.1 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Intangibles (2025 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Intangibles history runs 2 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Intangibles changed N/A year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (changed N/A YoY), while the FY2025 annual figure was $10.1 million, changed N/A from the prior year.
- Intangibles for Q1 2026 stood at $9.2 million, down from $10.1 million in the prior quarter.
- The five-year high for Intangibles was $10.1 million in Q4 2025, with the low at $9.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.12 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 9.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.24 Mn |
| Dec 31, 2025 | 10.12 Mn |